Blocking von Willebrand factor: a novel anti-platelet therapy.
Laffan
M
M
Department of Haematology, Imperial College Academic Health Sciences Centre, Hammersmith Hospital, London, UK. m.laffan@imperial.ac.uk
McKinnon
T A J
TA
D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013927:Thrombosis / Q000517:prevention & control*; D014841:von Willebrand Factor / Q000037:antagonists & inhibitors*
D010975:Platelet Aggregation Inhibitors; D014841:von Willebrand Factor